Number of pages: 120 | Report Format: PDF | Published date: 24 June, 2020
Historical Years – 2018 & 2019 | Base Year – 2020 | Forecasted Years – 2021-2031
The global cell analysis market was pegged at US$ 17.12 billion in 2020 and is expected to witness a CAGR of 7% during the forecast period.
Market Fundamentals
Cell analysis is a broad term that can be applied to a range of different technologies. Cell analysis is performed to evaluate and measure the current state of cells, such as cell integrity, toxicity, viability, and various other research applications. An integral part of cell analysis is data collection, analysis, and export into a meaningful and useful format. It plays a vital role in gene identification, protein identification epigenomics, and other life science-related areas.
[653453434]
Market Dynamics
The global cell analysis market is mainly driven by the rising incidence of chronic diseases coupled with the application of cell analysis in personalized medicine, increasing drug discovery & development activities, and technological advancements. Furthermore, increasing funding for cell-based research is also likely to play a pivotal role in driving the market globally. However, the high cost of cell analysis instruments and experiments is likely to restrain the market growth to a certain extent.
Market Ecosystem
The global cell analysis market has been analyzed from four perspectives: Offering, Application, End User, and Region.
Cell Analysis Market by Offering
[8765453]
Based on offering, the market has been segmented into consumables, instruments, and software. The consumables segment is further categorized into reagents, assay kits, and others (microplates, etc.). Whereas, instruments segment is further categorized into microscopes, flow cytometry, qPCR, high-content screening (HCS) systems, cell microarrays, spectrophotometer, and others (cell counters, next-generation sequencing, etc.). The consumables segment dominated the market with the largest share owing to frequent purchases and high usability of consumables such as reagents & assay kits, unlike instruments & software.
Cell Analysis Market by Application
Based on application, the cell analysis market has been segmented into cell identification, cell viability, cell signaling pathway/signal transduction, cell proliferation, cell counting & quality control, target identification & validation, single-cell analysis, and others (cell interaction, cell structure study, etc.). The cell identification segment dominated the market with the largest share. The cell identification process helps in identifying blood cells depending on their size, presence/absence of nucleus in the cell, and shape of the nucleus. Furthermore, it also assists in identifying tumor cells with the help of spectroscopy and microfluidics. These factors are expected to drive the growth of the cell identification segment.
Cell Analysis Market by End User
Based on end-users, the cell analysis market has been segmented into hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, academic and research institutes, and others (cell culture collection repositories, CROs, etc.). The pharmaceutical & biotechnology companies segment is expected to be the fastest-growing end-user segment during the forecast period. The growth of the segment can be mainly attributed to growing drug research & development activities. Cell analysis instruments & consumables are widely used in various stages of drug discovery, pharmacokinetics, toxicology, and clinical studies.
Cell Analysis Market by Region
Based on region, the global cell analysis market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). North America dominated the cell analysis market with the largest share, followed by the Asia Pacific. The large share of North America in the global market can largely be attributed to developed healthcare infrastructure, rising prevalence of chronic diseases, growing R&D activities, and growing government initiatives. Furthermore, the presence of prominent players in the region coupled with their continuous effort to launch technologically advanced cell analysis tools and instruments are also expected to propel the growth of the market.
Competitive Landscape
Some of the prominent players operating in the cell analysis market includes:-
Strategic Developments
Report Attribute |
Details |
Revenue forecast in 2031 |
US$ 36.03 billion |
Market size value in 2020 |
US$ 17.12 billion |
Growth Rate |
CAGR of 7% from 2021 to 2031 |
Base year for estimation |
2020 |
Forecast period |
2021-2031 |
Segments covered |
Offering, Application, End User |
Regional scope |
North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
The global cell analysis Market was anticipated to clock US$ 17.12 billion in 2020
The cell analysis market is projected to reach US$ 36.03 billion by 2031
The global cell analysis market is mainly driven by the rising incidence of chronic diseases coupled with the application of cell analysis in personalized medicine, increasing drug discovery & development activities, and technological advancements.
Beckman Coulter, Inc, Thermo Fisher Scientific, BD, Merck KGaA, Cytiva, Agilent Technologies, Inc, Olympus Corporation, PerkinElmer Inc, Promega Corporation, Sysmex
The growth rate of cell analysis market is CAGR of 7% between 2021-2031
North America held the largest share of the global cell analysis market in 2020
*Insights on financial performance is subject to availability of information in the public domain
Growth+Reports can now be customized as per client’s needs through GRG Health’s primary research and knowledge services capabilities
GRG Health’s unique GrowthMIX approach and robust research methodology helps us deliver unique & meaningful insights to our clients and uncover trends that won’t meet the standard approach